Sanobiotec Is A Lithuania Based Company Focused On Cannabinoid Research And Manufacturingfounded In 2018Officially Registered As Sanobiotecuab In 2020It Has Established Itself As A Global Player In Minor Cannabinoid Productionwith Operational Hubs In Chicagovilniusand Tokyo The Company Specializes In Developing And Scaling The Production Of Minor Cannabinoids For Both Commercial And Research Applicationskey Products Include Thcvcbncbcand Cbdvamong Othersall Produced With A Focus On High Purity And Iso Certified Standardssanobiotec Is Committed To Qualityholding Certifications Such As Iso 22716 2007 For Cosmetic Manufacturing And Iso 9001 2015 For Quality Managementthe Company Emphasizes Scalability In Its Manufacturing Processesoffering Next Day Delivery For Bulk Orderswith A Projected Revenue Growth From A 3M In 2023 To A 9M In 2024Sanobiotec Aims To Lead The Minor Cannabinoid Market By Addressing Production Challenges And Capitalizing On Global Regulatory Changes
